United Kingdom· GB-APID-38242911000001108
Eptifibatide 75mg/100ml solution for infusion vials
A eptifibatide product containing eptifibatide, registered in United Kingdom by Kensington Pharma Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eptifibatide is registered in 15 of 19 countries.
Countries holding a registration under ATC B01AC16 (eptifibatide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Eptifibatide · ATC B01AC16
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eptifibatide
- Manufacturer
- Kensington Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- B01AC16
- ATC class
- Eptifibatide
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060467000208
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for eptifibatide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eptifibatide · interactions on record
203 records
- 62 severe
- 76 moderate
- 65 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eptifibatide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StateseptifibatideSagent Pharmaceuticals
- FinlandEptifibatide AccordAccord Healthcare S.L.U.
- NetherlandsEptifibatide Accord 0,75 mg/ml oplossing voor infusieAccord Healthcare S.L.U.
- FranceEPTIFIBATIDE ACCORD 0,75 mg/ml, solution pour perfusionACCORD HEALTHCARE (ESPAGNE)
- PolandEptifibatide AccordAccord Healthcare S.L.U.
- SwedenEptifibatide Accord 0,75 mg/ml Infusionsvätska, lösningAccord Healthcare S.L.U.
- BelgiumEptifibatide Accord 0.75 mg/mlAccord Healthcare
- IrelandEptifibatide Accord 0.75 mg/ml solution for infusionAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Bulgaria · Ептифибатид Ромфарм
- Germany · Eptifibatid, Eptifibatid Altamedics
- Denmark · Eptifibatide "ctruz"
- Finland · Eptifibatide Ctruz
- Hungary · Eptifibatide Rompharm
- Ireland · Eptifibatide Jed
- Iceland · Eptifibatide Accord
- Italy · Eptifibatide Alida
- Liechtenstein · Eptifibatide Accord
- Netherlands · Eptifibatide Aftpharm
- Norway · Eptifibatide Accord, Eptifibatide Ctruz
- Romania · Eptifibatidă Rompharm
- Sweden · Eptifibatide Ctruz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1bfa38d-219f-4f94-a57f-8cb6f4d63599 GET /v1/drugs/c1bfa38d-219f-4f94-a57f-8cb6f4d63599?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38242911000001108",
"desc": "Eptifibatide 75mg/100ml solution for infusion vials (Kensington Pharma Ltd)",
"form": "Solution for infusion",
"vpid": "36064411000001100",
"source": "dmd",
"vtm_id": "775806008",
"strength": "750 microgram",
"substance": "Eptifibatide",
"ingredient": "Eptifibatide",
"supplier_code": "31307011000001102"
}See everything about eptifibatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.